Alseres Pharmaceuticals Inc (ALSE)
0.01
0.00 (0.00%)
USD |
OTCM |
Jun 25, 16:00
Alseres Pharmaceuticals Total Liabilities (Quarterly): 11.66M for June 30, 2014
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2014 | 11.66M |
March 31, 2014 | 11.38M |
December 31, 2013 | 11.05M |
September 30, 2013 | 27.78M |
June 30, 2013 | 27.42M |
March 31, 2013 | 27.15M |
December 31, 2012 | 27.69M |
September 30, 2012 | 33.12M |
June 30, 2012 | 31.36M |
March 31, 2012 | 31.13M |
December 31, 2011 | 30.77M |
September 30, 2011 | 44.63M |
June 30, 2011 | 44.14M |
March 31, 2011 | 48.84M |
December 31, 2010 | 47.75M |
September 30, 2010 | 46.94M |
June 30, 2010 | 51.64M |
March 31, 2010 | 50.10M |
December 31, 2009 | 48.30M |
September 30, 2009 | 47.67M |
June 30, 2009 | 45.35M |
March 31, 2009 | 43.36M |
December 31, 2008 | 40.86M |
September 30, 2008 | 39.53M |
June 30, 2008 | 39.53M |
Date | Value |
---|---|
March 31, 2008 | 33.88M |
December 31, 2007 | 28.04M |
September 30, 2007 | 27.29M |
June 30, 2007 | 18.32M |
March 31, 2007 | 22.78M |
December 31, 2006 | 18.94M |
September 30, 2006 | 4.789M |
June 30, 2006 | 2.264M |
March 31, 2006 | 2.414M |
December 31, 2005 | 2.624M |
September 30, 2005 | 2.549M |
June 30, 2005 | 1.784M |
March 31, 2005 | 1.752M |
December 31, 2004 | 1.976M |
September 30, 2004 | 6.166M |
June 30, 2004 | 5.983M |
March 31, 2004 | 6.091M |
December 31, 2003 | 5.317M |
September 30, 2003 | 5.380M |
June 30, 2003 | 5.235M |
March 31, 2003 | 5.454M |
December 31, 2002 | 5.705M |
September 30, 2002 | 5.667M |
June 30, 2002 | 2.269M |
March 31, 2002 | 2.470M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
Infinity Pharmaceuticals Inc | 58.64M |
Cantech Holding Inc | 0.873M |
Cardax Inc | 12.73M |
MetaStat Inc | 3.691M |
Nanobac Pharmaceuticals Inc | -- |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.279M |
Shareholders Equity (Quarterly) | -11.38M |